Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739102 · ClinicalTrials.gov registry record · NA
S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease
A NA study, sponsored by Cordis US.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT00739102 is a NA study that has completed, run by Cordis US. The registered enrollment target is 250 participants.
The verdict
NCT00739102, a NA study, has completed, sponsored by Cordis US.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
A multi-center, non-randomized, single-arm, prospective trial evaluating the safety and effectiveness of the S.M.A.R.T.™ Nitinol Stent System implantation in approximately 250 patients with obstructive superficial femoral artery disease.
Interventions
- DEVICE S.M.A.R.T. ® Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00739102
The ClinicalTrials.gov registry entry for NCT00739102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cordis US, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which S.M.A.R.T. ® Stent is the first listed.
NCT00739102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00739102 about?
NCT00739102 is a clinical study titled "S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease". A multi-center, non-randomized, single-arm, prospective trial evaluating the safety and effectiveness of the S.M.A.R.T.™ Nitinol Stent System implantation in approximately 250 patients with obstructive superficial femoral artery disease.
What is the current status of trial NCT00739102?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2008-08. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00739102?
The interventions under investigation include: S.M.A.R.T. ® Stent (DEVICE).
Who is sponsoring clinical trial NCT00739102?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.